Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ezerra is a specialized dermatological brand focused on the management of atopic dermatitis and sensitive skin conditions, particularly in pediatric populations. The brand is best known for its non-steroidal topical formulations, such as Ezerra Cream and Ezerra Lotion, which utilize naturally derived ingredients like Stimutex-AS and Saccharide Isomerate to provide anti-inflammatory and moisturizing effects. Originally developed and marketed by Hoepharma Holdings, the brand became part of the Taisho Pharmaceutical portfolio following the acquisition of Hoepharma. Ezerra products are widely distributed across Southeast Asia and other international markets as a safe, long-term alternative to topical corticosteroids for managing eczema flare-ups.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ezerra.